{"id":934019,"date":"2026-10-19T18:14:09","date_gmt":"2026-10-19T18:14:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/934019\/"},"modified":"2026-10-19T18:14:09","modified_gmt":"2026-10-19T18:14:09","slug":"penn-state-develops-multilayer-nanoparticle-rapid-syphilis-test","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/934019\/","title":{"rendered":"Penn State Develops Multilayer Nanoparticle Rapid Syphilis Test"},"content":{"rendered":"<p>Researchers led by Pennsylvania State University have developed a <a href=\"https:\/\/clpmag.com\/disease-states\/infectious-diseases\/std\/rapid-syphilis-tests-show-economic-clinical-benefits-high-risk-populations\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">pilot rapid diagnostic test<\/a> that integrates two clinical blood tests into a single device, enabling earlier detection of syphilis at low antibody concentrations.<\/p>\n<p>Detailed in a <a href=\"https:\/\/pubs.acs.org\/ascefj\/article\/doi\/10.1021\/acssensors.6c02500\/5275857\/Multilayer-Plasmon-Hybridization-in-Au-Ag-Au\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">study<\/a> published in ACS Sensors, the platform replaces standard gold nanoparticles with multilayer nanoparticles composed of a silver core sandwiched between two protective gold layers. This structure produces test lines that are 19% to 46% stronger than conventional lateral flow assays while reliably identifying both treponemal and non-treponemal antibodies in low-titer samples.<\/p>\n<p>Syphilis symptoms often mimic other conditions and can disappear without treatment while systemic damage progresses. Left untreated, the infection can be transmitted to sexual partners or passed to fetuses during pregnancy, leading to severe congenital complications.<\/p>\n<p>\u201cThe low-titer range, meaning the range with the lowest concentration of antibodies, is particularly challenging for detecting syphilis,\u201d says <a href=\"https:\/\/www.huck.psu.edu\/directory\/dipanjan-pan\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Dipanjan Pan<\/a>, Dorothy Foehr Huck and J. Lloyd Huck chair professor in nanomedicine at Penn State and corresponding author of the study, in a release. \u201cThis range is also clinically important, occurring during early infection, later stages of syphilis or after treatment when antibody levels are declining to make sure treatment worked.\u201d<\/p>\n<p>Preserving the CDC Diagnostic Algorithm<\/p>\n<p><a href=\"https:\/\/www.cdc.gov\/std\/treatment-guidelines\/syphilis.htm\" rel=\"nofollow noopener\" target=\"_blank\">Standard testing guidelines established by<\/a> the US Centers for Disease Control and Prevention (CDC) rely on a two-step laboratory pathway. The first test, a treponemal assay, detects antibodies specific to Treponema pallidum, which typically remain detectable in the body for decades, even following curative therapy. The second, a non-treponemal test, identifies antibodies generated in response to cellular damage, reflecting active infection, disease staging, and therapeutic response.<\/p>\n<p>While <a href=\"https:\/\/clpmag.com\/disease-states\/infectious-diseases\/std\/fda-grants-marketing-authorization-for-at-home-syphilis-test\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">two rapid syphilis tests have received clearance from the US Food and Drug Administration<\/a> in recent years, they detect only treponemal antibodies and cannot distinguish active from past treated infections. Currently, no single-step confirmatory syphilis tests are approved for clinical use in the US, and an existing European test does not detect antibodies in the low-titer range.<\/p>\n<p>\u201cWhat is important about our approach is that we are not asking clinicians to abandon this well-established diagnostic pathway,\u201d says Pan in a release. \u201cInstead, we are trying to reproduce the same sequence of diagnostic information in a much faster and potentially point-of-care format.\u201d<\/p>\n<p>Engineering Stronger Optical Signals at the Nanoscale<\/p>\n<p>Conventional lateral flow tests depend on gold nanoparticles accumulating to create a visible signal. However, increasing particle diameter beyond roughly 60 nanometers causes agglomeration and settling in fluid channels rather than smooth migration across the membrane.<\/p>\n<p>To overcome this physical constraint, the engineering team altered particle architecture using <a href=\"https:\/\/clpmag.com\/disease-states\/infectious-diseases\/covid-19\/nanoparticles-could-enable-more-sensitive-durable-rapid-covid-tests\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">localized surface plasmon resonance<\/a>. By encasing an optically active silver layer inside gold, the researchers prevented oxidative degradation while allowing electrons across the metallic boundaries to couple, generating a substantially stronger optical signal.<\/p>\n<p>\u201cAt the nanoscale, I like to picture the electrons on the particle\u2019s surface as the ripple of standing and sitting that happens when a stadium full of people participate in \u2018the wave,\u2019\u201d says Ketan Dighe, graduate student in biomedical engineering at Penn State and first author of the study, in a release. \u201cThat collective motion is called localized surface plasmon resonance, and when light hits them, it\u2019s what gives the particles their color and makes them so useful for detection.\u201d<\/p>\n<p>In laboratory benchmark evaluations, six times fewer multilayer particles were needed to produce a visible signal compared to gold nanoparticles alone, and the engineered particles remained visible with three times fewer target molecules.<\/p>\n<p>The investigators subsequently validated the platform using 36 clinical specimens provided by the CDC and Boca Biolistics across variable antibody concentrations. Test lines showed 19% to 46% intensity increases compared to standard gold nanoparticles, with the most pronounced gains observed in specimens containing the lowest antibody titers.<\/p>\n<p>Addressing Congenital Syphilis Surges<\/p>\n<p>Improving analytical sensitivity in point-of-care testing carries major public health implications. In 2024, <a href=\"https:\/\/clpmag.com\/disease-states\/infectious-diseases\/std\/rise-in-syphilis-cases-prompts-more-testing-during-pregnancy\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">nearly 4,000 infants in the US were born with congenital syphilis<\/a>, marking the 12th consecutive annual increase. According to CDC surveillance data, lack of timely testing and adequate treatment contributed to nearly 90% of those cases.<\/p>\n<p>\u201cSyphilis is one of those unique bacteria that can impact every single organ of the body,\u201d says <a href=\"https:\/\/pure.psu.edu\/en\/persons\/casey-pinto\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Casey Pinto<\/a>, PhD, associate professor of public health sciences at Penn State College of Medicine, and study co-investigator, in a release. \u201cIf we do not catch syphilis and the woman is pregnant, it could infect the child, too. The baby can be born with developmental delays, heart problems, blindness, teeth and bone malformations, skin rashes and it can even lead to death.\u201d<\/p>\n<p>Pinto noted that same-day confirmatory results could allow providers to deliver immediate counseling, education, and stage-appropriate treatment during a single patient encounter.<\/p>\n<p>The research team has submitted a patent application for the technology and is <a href=\"https:\/\/clpmag.com\/disease-states\/infectious-diseases\/std\/nih-awards-to-support-syphilis-diagnostics-innovation\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">seeking industry partners<\/a> to initiate broader clinical validation studies, complete prototype refinement, and pursue regulatory clearance.<\/p>\n<p>Photo caption: A new pilot rapid test for syphilis from a team led by Penn State researchers integrates two blood tests into one and detects bacteria at very low levels to detect the disease in its earliest stages.<\/p>\n<p>Photo credit: Pan Research Lab<\/p>\n","protected":false},"excerpt":{"rendered":"Researchers led by Pennsylvania State University have developed a pilot rapid diagnostic test that integrates two clinical blood&hellip;\n","protected":false},"author":2,"featured_media":934020,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[500892,500893,64,63,295046,131893,17974,500894,500895,500896,500897,500898,500899,128,500900,500901],"class_list":["post-934019","post","type-post","status-publish","format-standard","has-post-thumbnail","category-science","tag-acs-sensors","tag-antibody-detection","tag-au","tag-australia","tag-cdc-guidelines","tag-clinical-diagnostics","tag-infectious-disease","tag-lateral-flow-assay","tag-nanoparticle-diagnostics","tag-non-treponemal-assay","tag-penn-state-research","tag-point-of-care-testing","tag-rapid-diagnostic-test","tag-science","tag-syphilis-testing","tag-treponemal-assay"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/934019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=934019"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/934019\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/934020"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=934019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=934019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=934019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}